Among which, YTHDF1 [8], IGFBP1 [28], IGFBP2 [29], FTO [30], ALKBH5 [31], WTAP [32], YTHDC2 [33], and LRPPRC [34] have been previously reported to predict the prognosis of STAD patients. This evidence concerns the gene IGFBP1 and gastric adenocarcinoma.